The authors describe an assay to quantitate DNA fragmentation using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) stain, adapted to a 96-well microplate format for adherent cells, and an automated high-content screening imager. The apoptotic responses to actinomycin D (a known antineoplastic agent) to imiquimod (a smallmolecule toll-like receptor [TLR] 7 agonist used in skin cancer treatment) and to several structurally related TLR 7/8 agonists were evaluated in squamous carcinoma SCC15 and SCC25 cells and normal human keratinocytes. Potent proapoptotic and growth-impairing (as determined by reduced cell numbers) actions of actinomycin D (1-300 ng/mL) were discerned with the assay. Consistent with previous reports, imiquimod (at 300 µM; ∼75 µg/mL) induced TUNEL positivity of malignant cell cultures, but this effect also occurred in normal keratinocytes. Two related TLR agonists induced apoptosis at lower concentrations. However, the concentrations of these and the imiquimod necessary to elicit cancer cell apoptosis were 300 to 1000 times higher relative to their ability to induce the secretion of an antineoplastic protein,interferon-α, from human blood monocytes. This TUNEL analysis allows the quantitative comparison of compounds' apoptotic activity toward adherent malignant and normal cells and may be useful for hit characterization after a screen. (Journal of Biomolecular Screening 2006:575-585) 
INTRODUCTION

I
NDUCING APOPTOSIS OFFERS UTILITY for therapeutically treating disease, whether cancerous or noncancerous. Often, cellbased assays are used to monitor well-defined pathways such as cascades involving caspase-3.
1,2 However, drug-induced apoptosis of tumor cells may be mediated by caspase 3-independent cascades 3, 4 or it may be totally caspase independent. 5, 6 Thus, the common approach of apoptosis assays probing very specific and molecularly well-defined pathways [7] [8] [9] [10] [11] can give false-negative results.
DNA fragmentation assays based on terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) identify apoptosis regardless of the upstream mechanism because it identifies cells that have progressed to irreversible stages of apoptosis. Traditionally, individual cells' TUNEL stain was evaluated with manual microscopy, although there are now some newer methods. But methods to quantify apoptosis on adherent cell lines remain difficult. Technologies pairing fluorescence imaging/cytometry and informatics, termed cytomics, 12 offer added confidence that a given compound has anticancer activity. 2, 13, 14 The ArrayScan II (Cellomics, Inc.; Pittsburgh, PA) uses automated fluorescence microscopy, software algorithms, and information management to interrogate features of adherent cells. 15 In conjunction with the Cellomics high-content screen instrument, we adapted TUNEL staining for quantitation of adherent cell apoptosis. We also demonstrated utility of the assay in identifying the apoptotic responses caused by actinomycin D, a DNA intercalator known to inhibit RNA synthesis and to act as an antineoplastic agent. In addition, the method was tested on imiquimod and several related smallmolecule analogs, 3M-006, 3M-008, and 3M-030. Preclinical and clinical observations with imiquimod, a toll-like receptor (TLR) 7 agonist approved as a pharmaceutic, show that inflammatory cytokines are associated with its activity toward skin cancers such as squamous cell and basal cell carcinoma. [16] [17] [18] Such cytokines can initiate cell-mediated cytolytic activity, but there have also been reports of imiquimod mediating direct anticancer cell activity via apoptotic pathways. [19] [20] [21] We expanded on the manner and concentration in which these TLR 7/8 agonists exert an antitumor cell action in vitro. Finally, effects of the compounds were also compared using normal human epithelial keratinocytes (NHEKs) so that specificity of apoptotic activity toward the malignant phenotype could be delineated.
MATERIALS AND METHODS
Cells and culture conditions
Head and neck squamous carcinoma cell (SCC) lines SCC15 and SCC25 (ATCC; Manassas, VA) were cultured and maintained in a humidified atmosphere at 5% CO 2 and 37°C in RPMI 1640 (25 mM HEPES, 2 mM L-glutamine, and 1200 mg/L sodium bicarbonate). The medium was supplemented with 10% fetal calf serum (FCS; GIBCO, Gaithersburg, MD), 100 U/mL penicillin, and 100 µg/mL streptomycin sulfate (GIBCO), 1% nonessential amino acids (Sigma, St Louis, MO), 110 mg/L sodium pyruvate (Sigma), and 400 ng/mL hydrocortisone (Sigma). Cultures were trypsinized and passaged weekly at a spilt ratio of 1:5 for SCC15 or 1:10 for SCC25.
For comparison to malignant cells, normal human epidermal (basal) keratinocytes (NHEKs) from infant foreskin were purchased at passage 3 (Mattek, Inc., Ashland, MA). The NHEK cells were subcultured for use on passages 4 and 5. Proprietary basal NHEK medium from Mattek included 110 mg/L pyruvate and 180 ng/mL hydrocortisone. Culture conditions maintained the NHEKs in a continually dividing state using Mattek's NHEK culture medium (J. Kubilus, Mattek, Inc., personal communication). NHEK cells were seeded at 1 × 10 4 /well in 96-well plates overnight, and then the medium was switched to a corresponding hydrocortisone-free medium for an additional 16 to 20 h, with a confirmed >95% viability. The initial cell titer for a 96-well format was determined in preliminary experiments with SCC cell lines and undifferentiated NHEKs so that the cells would not reach confluency during time in culture.
Dosing of the SCC and NHEK cells with test compounds
Actinomycin D (Calbiochem, Inc., San Diego, CA) was used to confirm the algorithm and assay ultimately used for the apoptosis assessment. From a concentration of 10 mg/mL in DMSO, actinomycin D was diluted in hydrocortisone-free medium for use at 100 to 300 ng/mL. Test compounds for the experiments were the hydrochloride salt derivative of imiquimod (1-isobutyl-4(1H)-imidazo [4,5-c] quinolinamine; 3M Pharmaceuticals, St. Paul, MN) and related immune response modifier analogs 3M-030 and 3M-008 with agonist actions on TLR 7/8. Finally, the imidazo[4,5-c]quinoline 3M-006 was included as it is a related analog that does not induce interferon-α (IFNα ) from peripheral blood mononuclear cells (PBMCs; unpublished results). For TLR agonist dissolution, imiquimod HCl was directly soluble into medium whereas 3M-006, 3M-030, and 3M-008 were soluble in DMSO at a concentration of 30 mM. Each of the compounds was added to subconfluent cultures in each well in hydrocortisone-free medium to reach the desired final concentrations of 0.5, 1.5, 5, 15, 30, and 60 µΜ (and 100 and 300 µΜ for imiquimod only); the DMSO did not exceed 0.2%. The incubation selected (24 h, 37º C) for evaluating the efficacy of the action of compounds was modeled after the published reports for antiproliferative agents. Each assay condition was repeated on 3 to 6 separate experiments.
TUNEL and Hoechst stains
TUNEL staining was carried out to visualize and quantitate apoptosis using the DeadEnd Fluorometric reagents (catalog no. G3250; Promega, Inc., Madison, WI); the protocol was modified to permit cells maintained in 96-well microplates to be stained. Following exposure to the compounds, the cells were fixed by incubation in 4% formaldehyde (in phosphate-buffered saline [PBS]) for 30 min. Unless otherwise noted, all reagent additions and washes were in 50 µL per well and carried out at room temperature. Following each step, cells underwent 3 washes in PBS. Cells were permeabilized using 0.2% Triton-X (in PBS) for 45 min at 37º C to facilitate staining. DNase I (0.5 U/well) was a positive staining control. DNase I was added to the fixed cells for 20 min (37º C) before staining, which resulted in fragmentation of the chromosomal DNA and made multiple 3′-OH DNA ends available for labeling with dUTP. All wells received a solution containing equilibration buffer (180 mM potassium cacodylate, 22.5 mM Tris-HCl, 1.8 mM DTT, 0.225 mg/mL bovine serum albumin, 2.25 mM cobalt chloride), nucleotide mix (5 µM fluorescein-12-dUTP, 10 µM dATP, 1 mM Tris-HCl [pH 7.6]) and 15 U of recombinant terminal deoxynucleotidyl transferase (TdT) for 60 min at 37º C. Early experiments demonstrated that dUTP binding was specific and that elimination of TdT enzyme or nucleotides resulted in no TUNEL fluorescence. Cell nuclei were counterstained with 3 µg/mL Hoechst 33342 (in PBS) for 5 min. A final PBS wash removed any excess fluorophores. The plates were sealed and stored in PBS at 4º C until analysis, whereupon the fluorescein-12-dUTP-labeled DNA was visualized by fluorescence imaging.
High-content imaging
The ArrayScan II version 3.1 automated fluorescence imager (Cellomics, Inc., Pittsburgh, PA) rendered quantitative information on the intensity and localization of fluorescence signals on a cell-to-cell basis within 96-well microplates. The light source was a 200-W mercury-xenon lamp. Using a builtin autofocus routine with a high-resolution cooled 12-bit CCD camera and frame grabber, images of the fluorescence emissions were acquired (in separate channels) of the Hoechst and TUNEL stains transmitted through Hoechst/DAPI and fluorescein isothionate cubes (Omega Optical, Brattleboro, VT), respectively. Images in channel 1 were used for identifying and tracking individual Hoechst-stained nuclei, providing the basis for the region (i.e., an overlay) demarcating the intensity measurements in channel 2 (e.g., see Fig. 1 ). The Ch1 overlay also was used for the instrument to tabulate cell number/microscopic field ("cell number") and nuclear area across all the sampled wells. The image analysis algorithm distinguished cells based on the intensity difference between the Hoechst 33342-stained nuclear regions and unstained cytosol. Channel 2 measured fluorescence from fluorescein-12-dUTP incorporation in nuclei of cells selected in channel 1. 
Scanning and automated image analysis protocol
As part of determining the staining procedure yielding optimal DNAse I-induced TUNEL staining, a 2-channel imaging protocol was built on the highly flexible Target Activation BioApplication™ from Cellomics™. Only the pixels that fell under a particular defined overlay were used for measurement of changes in nuclear morphology and TUNEL positivity.
The protocol instruction collected images until an adequate number of microscope fields (350 µm square at 200 × magnification) were interrogated to collect 1500 objects (nuclei in channel 1; 500 objects/well in triplicate) per condition per experiment. In cases of exposure-induced decline in cell number, each group had assessed the total number of cells in up to 10 microscopic fields/well or 500 cells/well (whichever criterion was met first). To report the compounds' effects on populations of adhering cells, both the TUNEL intensity ("mean average intensity Ch 2") for each of the cells along with cell number/field ("object per field count") were tabulated. For comparison between diluent and DNase I (or actinomycin D), the TUNEL assay window was calculated taking into account the median response of both control and responding sample populations.
Although the cytometric analysis tracked features of individual cells, for the purposes of this study, we report the average response in the population of TUNEL intensity and cell number/field (i.e., cell number; along with point estimates/ SEM). To allow for comparisons of mean fluorescence intensity (MFI) and average cell number to be made across different experiments, experimental data from test compounds were subsequently normalized to their diluent control (e.g., DMSO) in each separate experiment and compiled across experiments. All values in the text and figures are presented as mean ± SEM of several independent experiments. Statistical analysis was performed using Prism GraphPad Software (San Diego, CA). The effects of actinomycin D (30 ng/mL) on the cell number, MFI, and nuclear area were separately evaluated for each cell type relative to control with Student's t-test (and Bonferroni correction). For the effects of imiquimod and the other TLR 7/8 agonists, ANOVA analysis within an end point was performed (with post hoc comparison to negative control using Bonferroni's multiple comparisons test, if applicable). Differences with a value of p < 0.05 were considered significant.
PBMC stimulation and analysis of cytokine secretion
Whole blood was taken from healthy human volunteers in accordance with practices established by the 3M Institutional Review Board. PBMCs were isolated from this blood by density gradient centrifugation using Histopaque 1077 (Sigma). Following 2 washes with Dulbecco's PBS without calcium and magnesium (BioSource, Camarillo, CA), the isolated mononuclear cells were resuspended in RPMI 1640 medium (Protide, St. Paul, MN) containing 25 mM HEPES, 2 mM L-glutamine, and 2.0 g/L sodium bicarbonate, 1% of a 100 × penicillin/streptomycin sulfate solution (BioSource), and 10% heat-inactivated FCS (BioSource). Test compounds in polypropylene tubes at 10 mM were each serially diluted (1:3 dilution) in RPMI medium to produce an 8-point dilution series ranging from 30 to 0.01 µΜ. Based on previously determined work on DMSO sensitivity of the cells, dilution of compounds was so as not to exceed greater than 0.6% DMSO final. PBMCs were incubated 20 to 24 h with the serially diluted compounds (or corresponding percentage of DMSO). The tissue culture supernatants were harvested and frozen at -20º C until use.
A multispecies IFNα enzyme-linked immunosorbent assay kit obtained from PBL Biomedical Laboratories (Piscataway, NJ) specifically detected all human IFNα subtypes except IFNα F (IFNA21), as previously described. 22 The human tumor necrosis factor-α (TNFα) antibody pair was obtained from BioSource (catalog no. AHC3419 and AHC3712). Antibody AHC3419 was biotin labeled, and antibody AHC3712 was BV-TAG labeled by BioVeris (formerly IGEN; Gaithersburg, MD). The use of these TNF kit reagents and the electrochemiluminescent reader (BioVeris) is described in more detail by Gorden et al. 23 Standard curves for the cytokines were generated using recombinant TNFα (R&D Systems, Minneapolis, MN) and IFNα (PBL Biomedical Laboratories), the latter gauged to the international standard for human IFNα provided by the National Institutes of Health (reference no. Gxa 01-901-535). All cytokine results were expressed in picograms per milliliter. The limit of reliable detection for IFNα and TNFα assays was 20 pg/mL and 24 pg/mL, respectively.
RESULTS
Cytomics method development: apoptotic effects of actinomycin D
Initial assay conditions were optimized for the SCC and NHEK cell lines with the positive staining control, DNase I. The software overlays were adjusted to apply correctly to the nuclei prior to interrogating TUNEL MFI (Fig. 1, top) . Comparing the population responses in medium versus DNase I across multiple experiments indicated similar TUNEL assay characteristics, as demonstrated by box plots of the distribution of the cell populations' TUNEL intensity values (Fig. 1,  bottom) . The assay windows for TUNEL fluorescence among cells incubated in DNase I relative to that of the medium ranged from 36-to 132-fold across the experiments.
A variety of concentrations of actinomycin D triggered apoptosis (after 24-h incubation), based on microscopic visualization by a trained observer. Figure 2 shows the multichannel fluorescence images of cell populations exposed to actinomycin D (100 ng/mL, 24 h) obtained with the imager and the software-applied overlays around cell nuclei. Some cells positive for TUNEL that remained attached after the exposure had condensed nuclei (defined as compacted, shrunken nuclei), a hallmark of apoptosis. Also, cell loss was evident; many of those cells no longer attached were TUNEL positive and were not quantified by the imager. Figure 2 also depicts the population responses obtained from the automated imager when individual cellular TUNEL intensity was plotted for an SCC25 culture exposed to DMSO or actinomycin D (100 ng/mL). Exposure to actinomycin D (1-300 ng/mL) resulted in concentration-dependent increases in average TUNEL MFI values (Fig. 3) . Although the responses of all cell types were elevated at 30 ng/mL and higher, the SCC25 cells exhibited the most marked apoptotic signals at these concentrations. Such change in individual TUNEL stain intensity was often concomitant with a dose-dependent decline in the number of adherent cells, where 50% growth inhibition was reached at 30 ng/mL and 100 ng/mL in SCC25 and SCC15 cells, respectively. Cell number did not reach this 50% threshold in the NHEK at the concentrations tested.
Actinomycin D (30 ng/mL, 24 h) was deemed to be useful as a positive control yielding sufficient retention of cells on the plate and was included in each of the experiments involving TLR agonists. It resulted in robust increases in the SCC cells' TUNEL MFI (reaching levels as high as 16-fold greater than control), a less dynamic (but still significant) decline in cell number, and an insignificant change in Hoechst-stained nuclear area ( Table 1 ). The lack of an effect by actinomycin D on population measurements of nuclear area among the remaining adherent nuclei sampled was in contrast to the obvious nuclear condensation (the end stage of apoptosis) exhibited by detached nuclei in the medium when viewed using the microscope (not shown). Thus, because this assay quantifies attached cells, nuclear area changes were not subsequently investigated.
Apoptosis-inducing activity measured with the automated fluorescence imager: effects of imiquimod and related analogs
After determining the maximum change possible for the chosen cell types, we subsequently examined the ability of the TLR 7/8 agonists to induce TUNEL positivity and affect cell number in the SCCs and NHEKs. The multivariate analysis was facilitated by the substantially shorter hands-on time required to obtain TUNEL measurements using the high-content screening (HCS) imager. Four and one-half hands-on hours were necessary for performing a low throughput (conventional) assessment of a 96-well plate (per same selection criteria as in the Methods section) using a digital camera and Image software (Scion Corporation, Frederick, MD). In contrast, the automated imager offered walk-away scan times of typically 40 min. This 1 plate comprised approximately one-twentieth of the entire project and underscores the efficiency of the analysis with the HCS imager. Figure 4 shows representative multichannel images and the overlays of HCS imager-detected cells of SCC15, SCC25, and NHEK cultures exposed to 100 µM imiquimod.
The normalized MFI readings for cells exposed to diluent control had variations in the point estimate (SEM) of 8%, 18%, and 19% for the SCC15, SCC25, and NHEK cells, respectively, across 8 experiments. Normalized mean cell numbers showed similar variation among cultures dosed with the diluent control, having values of 100% ± 13%, 100% ± 13%, and 100% ± 15% for the same cell types, respectively. Incubation with imiquimod resulted in no significant DNA strand breaks in each cell type until 300 µM (∼75 µg/mL), relative to each cell type's control (p < 0.05 for each post hoc, pairwise comparison, following 1-way ANOVA; Fig. 5, left) . Relative to diluent control, cell number was not significantly altered in any of the cells given imiquimod.
Effects of 3M-030 and 3M-008 on TUNEL intensity and cell number varied somewhat from exposure with imiquimod (Fig. 5) . For example, 3M-030 and 3M-008 induced statistically significant TUNEL increases at concentrations of 60 and 30 µM, respectively. Also, reductions in average cell number were induced in SCC cell types by 3M-008 relative to control. Compound 3M-006 (not shown) failed to significantly alter these end points in the malignant or normal cells at 1.5 to 60 µM, where the highest 3M-006 exposure elicited in SCC15, SCC25, and NHEK cells is an average TUNEL MFI of 0.90 ± 0.1, 1.1 ± 0.1, and 1.2 ± 0.3, respectively, relative to diluent control values of 1.0. Compared to diluent-treated NHEK cells, 1.5 µM 3M-030 caused a slight decrease in the TUNEL MFI and also caused a slight increase in cell number (though not significant, this was also observed for imiquimod and 3M-008 exposures of 1.5 and 5 µΜ). The meaning of this slight attenuation in normal cell apoptosis by these compounds at low concentration is unclear.
Cytokine elicitation from PBMC-stimulated supernatants
The TUNEL and cell number results demonstrate that high concentrations of the TLR 7/8 compounds are necessary to cause a direct apoptotic effect on the SCC cells. Killing of similar SCC cells on administration of recombinant IFNα has been reported, 24, 25 and circulating IFNα is known to be a biomarker for the antitumor properties conferred by imiquimod in vivo. 26 Using blood monocyte cultures, a main source of imiquimod-stimulated IFNα, 22 we next ascertained those TLR 7/8 agonists concentrations necessary to stimulate IFNα. The thresholds at which IFNα was elicited above background levels with imiquimod, 3M-008, and 3M-030 were 1.0, 0.03, and 0.1 µΜ, respectively ( Table 2 ). Higher concentrations of these compounds were needed to induce TNF, another indicator that inflammatory cells are active. Compounds 3M-008 and 3M-030 elicited IFNα (and TNFα) levels that reached 1 ng/mL in the medium. Finally, at the concentrations examined, 3M-006 was ineffective at eliciting IFNα or TNFα release from PBMCs. Based on this, imiquimod, 3M-030, and 3M-008 stimulated human immune cells at concentrations 300, 600, and 1000 times lower, respectively, than that which caused significantly elevated TUNEL positivity under similar conditions. 
96 ± 23 100 ± 30 59 ± 8* 100 ± 16 45 ± 8* 100 ± 20 Nuclear area (%) 97 ± 56 100 ± 41 101 ± 27 100 ± 20 91 ± 32 100 ± 12 TUNEL = terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling; MFI = mean fluorescence intensity. a. Cells were stimulated with hydrocortisone-free medium alone or actinomycin D (30 ng/mL) in hydrocortisone-free medium for 24 h. Adherent cells were fixed and processed in the TUNEL assay and nuclei stained with Hoechst dye prior to Cellomics ArrayScan II analysis for the parameters listed. b. Within an experiment, the parameters were normalized to the average of wells receiving media (TUNEL intensity set to 1 and cell number and nuclear area each set to 100%) and compiled across the experiments. Results represent the mean ± SEM of 3 to 6 separate cultures. *p < 0.05 after t-test, relative to media for that condition.
FIG. 4.
ArrayScan images of entire microscopic fields (at 200 × magnification) of cells treated with imiquimod (100 µM, 24 h). Color images of Hoechst 33342 (blue) and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL; green) fluorescence channels are shown for normal human epithelial keratinocyte (NHEK), SCC15, and SCC25 cells ("merged").
The right column of images shows the TUNEL fluorescence in NHEK, SCC15, and SCC25 nuclei of the same cells shown in the merged images. Only the pixels falling under the a particular defined nuclear area (red overlay) were used for measurement of TUNEL positivity.
DISCUSSION
Our current study of apoptosis analysis of SCCs in parallel with normal human keratinocytes was conducted with the added quantification from a cytomics evaluation. This method recorded the apoptotic end point independent of the molecular heterogeneity of particular proteins in the death machinery. Although the steps of the TUNEL assay remain basically the same as published for Promega's Apoptosis DeadEnd™ detection reagents, they are adapted to 96-well microplates to be aligned with the automated image acquisition and analysis. Although there is the possibility for TUNEL reaction to stain cells in culture undergoing secondary necrosis (following apoptosis if there are no phagocytic cells to clear them), a systematic examination that combined TUNEL with the nuclear morphology stain, Hoechst, and the vital dye, propidium iodide, showed a low incidence of cells actually exhibiting this specificity problem. 27 Microplate reader-based assays for tumor cell viability predict compound potency well (some being capable of high-throughput screening), 28 but quantifying that death as an apoptotic phenotype across many samples efficiently has been addressed only recently (e.g., with DELFIA ® assay by Perkin Elmer or Guava Inc.'s TUNEL assay). Older methods used to measure DNA damage, such as pulsed-field gel electrophoresis and microplate assays based on fluorescent DNA intercalators, measure only the average responses of a large number of cells. The cell-based assay described herein has advantages over common methods involving trypsinization and flow cytometry or manual counting of TUNEL-stained slides in that they can be laborious and time-consuming. The benefits offered by this assay over manual evaluation on a sample-by-sample basis are clear; namely, the rapid quantification of the apoptotic end point in an automated manner accelerates the R&D cycle in drug discovery. Also, miniaturization brings some cost reduction because less amounts of compound and assay reagents are used. The methods employed here for dosing, fixing, permeabilizing, washing the cells, and processing the TUNEL stain are adaptable to a higher-throughput format with the use of liquid handlers. With such adaptation of the TUNEL method, a secondary assay following a screen would be possible, especially upon incorporating the plate handler for processing stacks of plates through the imager.
It was important to select the positive control to exert effects consistent with the exposure duration and cell type (mitotically active or not) used for the test compounds. For example, another nonchemotherapy drug often used for such studies is staurosporine. 3, 29, 30 With actinomycin D, all the cell types (whether malignant or not) responded, with SCC25 cells having greater responses relative to SCC15 or NHEK cells (cf. Fig. 3 and Table 1 ). These responses to actinomycin D were consistent with an earlier evaluation of actinomycin D for its proapoptotic action (selectively without necrosis) in pancreatic cancer cell lines where DNA fragmentation was evaluated with a number of methods. 31 Although useful for identifying robust TUNEL MFI and cell number changes, our imaging approach did not reveal the expected alterations in nuclear area on exposure to actinomycin D. Reasons that could have contributed to the paucity of nuclear area changes detected by the imager are 1) SCC and NHEK nuclei not having robust morpohologic changes at the stage of actinomycin D-induced apoptosis where they remain adherent or 2) the cell populations having a mixture of unaffected nuclei along with still adherent condensed and fragmented nuclei (this is the more likely option as reflected by the considerable variation around each point estimate in Table 1 ). Because this methodology excludes quantifying detached apoptotic and necrotic cells, should there be excessive cell loss using the chemicals or cell lines of interest, one may adjust the length of exposure downward, as necessary.
Existing detection methods based on TUNEL to interrogate apoptotic phenotype 27, 32, 33 have the criticism that mechanistic knowledge is not obtainable with such a phenotypical readout. But this, too, is the case when employing a multiparameter profile of apoptotic signals such as changes in mitochondrial membrane permeability, caspase 3 intensity, and nuclear size, 2 although that does narrow to some extent the cascades invoked. The method here could be adapted to cell-death measures with clinic samples. Ochs et al. and others described an ex vivo chemoresponse assay used for tumor biopsy samples wherein surrogate measures of cell death (non-TUNEL) using various microscope-based parameters provided a correlation between apoptosis and clinical responses to chemotherapeutic drugs. 34, 35 The TUNEL method herein fits with this paradigm, and the inclusion of normal cells permits a better understanding of any selective compound-induced growth impairing/apoptotic action on the malignant cells and potentially permits better management of the benefit-risk ratio for the patient.
Effectiveness and potency of cell-based responses among TLR 7/8 agonists
Previous studies provide data to support immune-mediated antitumoral effects [16] [17] [18] 36 as well as a direct anticancer cell action of imiquimod. [19] [20] [21] The antineoplastic protein IFNα can be detected in vitro at an elevated concentration when measured from supernatants of blood monocyte cultures stimulated with TLR 7/8 agonists. 22, 23 Our cell-based cytokine data show that the range of imiquimod concentrations for immune cell activation was 300 to 1000 times lower than required for triggering apoptosis directly in the SCCs. Our results also showed that these immune response modifiers generally mediated a nonselective apoptosis in both the malignant and normal cells that, for the most part, was well below that of the 10-to 20-fold increases elicited by actinomycin D. The dose response for imiquimod in SCCs is consistent with that previously characterized in A431, HaCaT, and McCoy cells using a manual TUNEL quantification as the end-point determination. 20 Similarly, the apoptosis we identify at 300 µM (∼75 µg/mL) was consistent with what has been reported. 19 However, this was the 1st examination of SCC25 as well as nontransformed (normal) epithelial cells. Like
